EQS Newswire

The newsfeed available here is provided by our content partner EQS Group. This is one of the most important and widest-reaching press services in the D-A-CH region, providing news, press releases and multimedia content to the media, journalists and the public.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
F&G: 35
5.523,04 S&P · 23,48 Vola-Index · 94.413,71 BTC · 1,13637 EURUSD
System-State: Number of processed items 51.847 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              
Der EQS-Newsfeed ist eine wichtige Nachrichtenquelle, die über das X-Billboard abgerufen werden kann. Sie ist Teil des Newswire-Hub, der für Börsianer wichtige internationalen Nachrichtenquellen an einem zentralen Ort bündelt. Wer sich schnell einen Überblick verschaffen will, kann sich bequem durch die Headlines scrollen. Wer sich detailliert mit den Nachrichten auseinandersetzen möchte, kann über die Detailansichten der Info-Cards direkt auf die jeweilige Nachricht und weitere Analysewerkzeuge zugreifen.
NEWS
EXPLORER
DE000A12ULL2
State: 03.08.2023 | 6PM
Do you already know our new terminal view? Click here.
FIGI: BBG00KT89QC6
NMI
Aladdin Healthcare Technologies SE
GICS: - · Sector: - · Sub-Sector: -
NAME
Aladdin Healthcare Technologies SE
ISIN
DE000A12ULL2
TICKER
NMI
MIC
XDUS
REUTERS
NMI.DE
BLOOMBERG
NMI GR
Mon, 15.08.2022       Aladdin Healthcare
DE000A12ULL2

Berlin, Germany, 15 August 2022 - Aladdin Healthcare Technologies SE ("the Company") announces that the German Federal Financial Supervisory Authority (BaFin) has informed the Company that it intends to impose fines in the total of approximately EUR 155,000 against the Company. Subject of the fines are late and incomplete financial and half-yearly ...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Mon, 15.08.2022       Aladdin Healthcare
DE000A12ULL2

Berlin, Germany, 15 August 2022 - Aladdin Healthcare Technologies SE ("the Company") announces that the German Federal Financial Supervisory Authority (BaFin) has informed the Company that it intends to impose fines in the total of approximately EUR 155,000 against the Company. Subject of the fines are late and incomplete financial and half-yearly ...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Wed, 24.11.2021       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies SE approved for Listing on OTCQB in the USA BERLIN/LONDON November 24, 2021 - Aladdin Healthcare Technologies SE ("Aladdin", ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, announces that it has gained approval from OTC Markets G...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Wed, 14.07.2021       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies with new research findings on COVID-19 diagnosis BERLIN/LONDON, July 14, 2021 - Aladdin Healthcare Technologies SE ("Aladdin", ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, is one of the co-authors of a high-impact review on th...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Tue, 18.05.2021       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies SE reports the sale of software and intellectual property BERLIN/LONDON, 18 May 2021 - Aladdin Healthcare Technologies SE (the "Company") reports that its 100% subsidiary Aladdin Healthcare Technologies Ltd ("Aladdin Ltd") has today completed the sale of specific software and intellectual property to a customer based...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Fri, 22.01.2021       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies signs Agreement to build proprietary Genomic Data Blockchain Platform with Zero Knowledge Proof BERLIN/LONDON January 22, 2021 - Aladdin Healthcare Technologies SE ("Aladdin", ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, has si...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Tue, 08.12.2020       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies SE reports preliminary figures for financial year 2019 and readjustment of the 2018 financial year figures Aladdin Healthcare Technologies SE (the "Company") reports that in the course of the preparation of its consolidated annual financial statements under IFRS for the financial year 2019, losses in the amount of EU...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Mon, 09.11.2020       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies discovers anti-osteoporosis nanomolar activity leads from natural compounds dataset with its Deep Learning Algorithms for drug discovery, validated by leading scientific publication "European Journal of Medicinal Chemistry" - Innovative deep learning algorithms allow a successful virtual screening of anti-osteoporos...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Thu, 08.10.2020       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies completes AI-driven Drug Discovery Platform (AIDD) for Commercial Use in Drug Development   - Aladdin has successfully released its proprietary AI Drug Discovery Platform to accelerate the drug development process. - The automated machine learning platform pipeline covers main stages of early drug discovery: Virtu...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Thu, 24.09.2020       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies will obtain an equity stake in public spinoff No-Age Biotech Inc. at TSX, aimed to combat age-related diseases   - Aladdin has agreed to obtain a 25% equity stake in No-Age Biotech Inc., publicly traded spinoff at TSX, in late 2020. - No-Age Biotech will be focused on the development of therapeutics to combat age-r...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Mon, 21.09.2020       Aladdin Healthcare
DE000A12ULL2

  Aladdin Healthcare Technologies completes Biomedical Knowledge Graph for Commercial use In Drug Development - Proprietary Knowledge Graph 'PharmaKG' released as Software As A Service (SAAS) - PharmaKG makes key findings of potential drug candidates visible - PharmaKG identifies target molecules, pathological causalities and new fields of appl...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Tue, 15.09.2020       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies signs with leading Market Maker and Broker for OTCQX Listing in the USA - US Listing of Aladdin shares planned to start in late October - The innovative expertise of MCAP matches perfectly Aladdin's needs within the US stock market - Cooperation with US pioneering electronic market maker enhances liquidity of the ...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Mon, 31.08.2020       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies achieves OTCQX listing in the USA - Aladdin shares enter world's largest technology market - US listing makes Aladdin more appealing for international investors - More availability and better profile of Aladdin shares through OTCQX listing BERLIN/LONDON, August 31, 2020 - Aladdin Healthcare Technologies SE ("Aladdi...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Thu, 30.07.2020       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies validates its proprietary Deep Learning Algorithms that significantly improve Drug Discovery Performance - Aladdin develops a new deep learning method for drug discovery with superior performance validated on six chemical property and toxicity datasets - Average prediction performance improved by 5-10% compared to ...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Tue, 28.07.2020       Aladdin Healthcare
DE000A12ULL2

Aladdin Healthcare Technologies becomes a sponsor of University College London's (UCL) Industry Exchange Network (IXN) Programme BERLIN/LONDON, July 28, 2020 - Aladdin Healthcare Technologies SE ("Aladdin", ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, was appo...
Read more
Aladdin Healthcare
Technical Analysis Termsheet Terminal
Permalink
Consequat mollit laboris sit voluptate duis duis mollit irure labore eu excepteur sit. Laboris cupidatat ullamco duis pariatur consequat culpa consectetur ex deserunt irure aute. Occaecat voluptate quis reprehenderit commodo minim aliquip sunt sint mollit. Magna enim ullamco amet ipsum cillum quis ipsum consectetur Lorem nostrud esse nisi. Nisi ut officia culpa ad id magna est aliqua consectetur est.